Use of maximal dosage renin-angiotensin-aldosterone system inhibitors in a real life population of complicated type 2 diabetes – contraindications and opportunities

Pharmacological inhibition of the renin-angiotensin-aldosterone-system (RAASi) is the cornerstone of hypertension treatment, renoprotection and secondary prevention of cardiovascular disease in patients with t...

Source: BMC Nephrology - August 16, 2023 Category: Urology & Nephrology Authors: C. M. Gant, M. M. Oosterwijk, S. H. Binnenmars, G. J. Navis, H. Haverkate, S. J. L. Bakker and G. D. Laverman Tags: Research Source Type: research